International audiencePatients in end-stage heart failure can experiment cardiogenic shock and may not be weanable from dobutamine. The fate of these patients is a challenge for doctors, patients, family, and the institution. Dobutamine use at home can be a solution. The aim of the present study was to assess the outcome, biological predictors, and safety of dobutamine use at home in dobutamine-dependent patients. All consecutive dobutamine-dependent patients discharged with continuous home intravenous dobutamine, from a single tertiary center between February 2014 and November 2019, were retrospectively analyzed. A total of 19 patients (age 65 ± 10 years) were followed for one year. At one-year, the survival rate was 32%, (6/19). Five (26%...
AbstractBackground:Dobutamine, a predominantly beta-adrenergic sympathomimeticagent, is used for imp...
Abstract Dobutamine is commonly used worldwide and included in the protocol for early goal-directed ...
To assess the clinical outcomes of levosimendan and dobutamine in patients with acute decompensated ...
International audiencePatients in end-stage heart failure can experiment cardiogenic shock and may n...
OBJECTIVE: To evaluate the results of intravenous dobutamine therapy at home for ambulatory patients...
Thirteen ambulatory patients with severe congestive heart failure were treated with weekly outpatien...
OBJECTIVE: To evaluate the results of intravenous dobutamine therapy at home for ambulatory patients...
Background: Though controversial, the short-duration in-patient use of inotropes in cardiogenic shoc...
Background Serial measurement of natriuretic peptides may guide management in heart failure (HF) pat...
Background Serial measurement of natriuretic peptides may guide management in heart failure (HF) pat...
severe cardiac failure. The cardiovascular effects of the continuous infusion of dobutamine in patie...
What is known and objective:Continuous infusion of dobutamine plays an important role in the managem...
BackgroundThe detrimental effects of inotropes are well-known, and in many fields they are only used...
CONTEXT: Because acute decompensated heart failure causes substantial morbidity and mortality, there...
Background: Serial measurement of natriuretic peptides may guide management in heart failure (HF) ...
AbstractBackground:Dobutamine, a predominantly beta-adrenergic sympathomimeticagent, is used for imp...
Abstract Dobutamine is commonly used worldwide and included in the protocol for early goal-directed ...
To assess the clinical outcomes of levosimendan and dobutamine in patients with acute decompensated ...
International audiencePatients in end-stage heart failure can experiment cardiogenic shock and may n...
OBJECTIVE: To evaluate the results of intravenous dobutamine therapy at home for ambulatory patients...
Thirteen ambulatory patients with severe congestive heart failure were treated with weekly outpatien...
OBJECTIVE: To evaluate the results of intravenous dobutamine therapy at home for ambulatory patients...
Background: Though controversial, the short-duration in-patient use of inotropes in cardiogenic shoc...
Background Serial measurement of natriuretic peptides may guide management in heart failure (HF) pat...
Background Serial measurement of natriuretic peptides may guide management in heart failure (HF) pat...
severe cardiac failure. The cardiovascular effects of the continuous infusion of dobutamine in patie...
What is known and objective:Continuous infusion of dobutamine plays an important role in the managem...
BackgroundThe detrimental effects of inotropes are well-known, and in many fields they are only used...
CONTEXT: Because acute decompensated heart failure causes substantial morbidity and mortality, there...
Background: Serial measurement of natriuretic peptides may guide management in heart failure (HF) ...
AbstractBackground:Dobutamine, a predominantly beta-adrenergic sympathomimeticagent, is used for imp...
Abstract Dobutamine is commonly used worldwide and included in the protocol for early goal-directed ...
To assess the clinical outcomes of levosimendan and dobutamine in patients with acute decompensated ...